0001892756-24-000001.txt : 20240111 0001892756-24-000001.hdr.sgml : 20240111 20240111133723 ACCESSION NUMBER: 0001892756-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240111 DATE AS OF CHANGE: 20240111 EFFECTIVENESS DATE: 20240111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eutropics Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001892756 ORGANIZATION NAME: IRS NUMBER: 202971708 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-502177 FILM NUMBER: 24528809 BUSINESS ADDRESS: STREET 1: 767 CONCORD AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 617-714-4405 MAIL ADDRESS: STREET 1: 767 CONCORD AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02138 D 1 primary_doc.xml X0708 D LIVE 0001892756 Eutropics Pharmaceuticals, Inc. 767 CONCORD AVENUE CAMBRIDGE MA MASSACHUSETTS 02138 617-714-4405 DELAWARE None None Corporation true Michael Cardone 767 Concord Avenue Cambridge MA MASSACHUSETTS 02138 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false true false true true Simple Agreement for Future Equity false 0 350000 0 350000 false 0 0 0 0 true false Eutropics Pharmaceuticals, Inc. /s/ Michael Cardone Michael Cardone CEO 2024-01-11